-Down to Earth Sivasankaran's land grabbing spree has threatened millions of livelihoods, says report Indian origin businessman Chinnakannan Sivasankaran has engaged in aggressive land grabbing of more than half a million hectares across Africa, Asia and South America, putting millions of livelihoods at risk. This was revealed in a detailed report released by Barcelona-based non-profit GRAIN on Tuesday. The report says Sivasankaran diverted 0.56 million hectares of food-producing land to production of palm...

-The Hindu   Instead of reinventing or restructuring the Planning Commission, we need to replace it with a think tank that supports high-quality independent research The Planning Commission is neither a constitutional nor a statutory body, but over the years it has acquired tremendous power of distant planning which is unsuitable to a country as diverse and complex as India. Let us neither reinvent nor restructure such a body. Let us, instead, make...

-The Hoot We can either spend another year discovering how much the old model is disintegrating or we can explore alternatives. But India has not developed a tradition as yet of not-for-profit journalism, says SEVANTI NINAN. Two recent developments at the New York Times and at Time Inc. which publishes Time magazine underscore the fact that financing has and will remain become the number one issue for the future of journalism as...

-The Economic Times When the voting stops on August 19, the scorecard, which is currently 9-0, may well read 12-0. An emphatic and embarrassing rejection of state and corporate plans to mine bauxite atop the Niyam Dongar hilltop in the Kalahandi district of Odisha. Twelve tribal villages that call this mountain range home have, in all likelihood, secured their religious rights over the hill and its natural resources, including 72 million...

-Reuters BRUSSELS: Nine drugmakers, including Denmark's Lundbeck and India's Ranbaxy, were fined a total of 146 million euros by EU antitrust regulators on Wednesday for blocking the supply of a cheaper anti-depressant medicine to the market. The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. The EU action came two days...